{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02460770",
      "OrgStudyIdInfo": {
        "OrgStudyId": "13 150 03"
      },
      "Organization": {
        "OrgFullName": "University Hospital, Toulouse",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device",
      "OfficialTitle": "Pilot Study of Investigation of Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device",
      "Acronym": "MESAD"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2018",
      "OverallStatus": "Withdrawn",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "June 2015",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 2017",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "June 2017",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 22, 2015",
      "StudyFirstSubmitQCDate": "May 29, 2015",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "June 2, 2015",
        "StudyFirstPostDateType": "Estimate"
      },
      "LastUpdateSubmitDate": "January 3, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 5, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University Hospital, Toulouse",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Thoratec Corporation",
            "CollaboratorClass": "INDUSTRY"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "Left Ventricular Assist Devices are commonly used to assist failing hearts as a bridge to transplantation or for long-term support. The purpose of the MESenchymal stem cell therapy and Left Ventricular Assist Device program is to improve heart function with stem cell therapy and attempt to wean patients from HeartMate Left Ventricular Assist Device.",
      "DetailedDescription": "Currently Left Ventricular Assist Device-only patients are being implanted and followed. Feasibility of autologous mesenchymal stem cell grafting in patients receiving heart mate will be assessed in a 4 patient pilot trial. Mesenchymal stem cell are delivered during Left Ventricular Assist Device surgery by intramyocardial infusions. Recovery of contractile function of the heart is assessed during attempts to wean patients from Left Ventricular Assist Device"
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Myocardial Ischemia"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Left Ventricular Assist Device",
          "stem cell therapy",
          "ischemic heart failure"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "0",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "autologous mesenchymal stem cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "After bone-marrow aspiration by an authorized person, Mesenchymal Stem Cells were isolated and cultured during 17 days by the French Blood Establishment. Then, patients receive intramyocardial injections of Mesenchymal Stem Cells during Left Ventricular Assist Device surgery",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Autologous mesenchymal stem cells"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Drug",
            "InterventionName": "Autologous mesenchymal stem cells",
            "InterventionDescription": "After bone-marrow aspiration by an authorized person, mesenchymal stem cells were isolated and cultured during 17 days by the French Blood Establishment. Then, patients receive intramyocardial injections of mesenchymal stem cells during device surgery.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "autologous mesenchymal stem cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "MSC"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Feasibility of the full procedure",
            "PrimaryOutcomeDescription": "ability to perform bone marrow aspiration, cell culture and intramyocardial injections during left Ventricular Assist Device surgery Realization of a full injection procedure",
            "PrimaryOutcomeTimeFrame": "1 month"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Ejection Fraction",
            "SecondaryOutcomeDescription": "Global and regional contractile function during echocardiography",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Maximal Oxygen consumption",
            "SecondaryOutcomeDescription": "Maximum rate of oxygen consumption as measured during incremental exercise, modification of the body mass (muscular lean mass, muscular strength), duration of the test and load,",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Walking distance in 6 minutes",
            "SecondaryOutcomeDescription": "measure of walk distance during six minutes",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "weaning procedure",
            "SecondaryOutcomeDescription": "progressive reduction of the pump speed",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Quality of life",
            "SecondaryOutcomeDescription": "assessment of quality of life by Minnesota Living with Heart Failure Questionnaire",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Measure of heart pressures",
            "SecondaryOutcomeDescription": "measure of heart pressures and cardiac output",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Brain natriuretic peptide",
            "SecondaryOutcomeDescription": "assessment of variation of brain natriuretic peptide",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Troponin",
            "SecondaryOutcomeDescription": "assessment of variation of troponin",
            "SecondaryOutcomeTimeFrame": "12 months"
          },
          {
            "SecondaryOutcomeMeasure": "Major bleeding",
            "SecondaryOutcomeTimeFrame": "1 month"
          },
          {
            "SecondaryOutcomeMeasure": "Systemic embolism",
            "SecondaryOutcomeTimeFrame": "1 month"
          },
          {
            "SecondaryOutcomeMeasure": "Deaths",
            "SecondaryOutcomeTimeFrame": "1 month"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "INCLUSION CRITERIA:\n\nPostmenopausal female or female who may become pregnant but is using adequate contraceptive precautions with negative pregnancy test,\nSevere Left Ventricular dysfunction with Ejection Fraction < 30% with ischemic cardiomyopathy,\nNew York Heart Association Class III or IV,\nNo revascularization options available,\nListed or not for cardiac transplantation,\nClinical indication and accepted candidate for Left Ventricular Assistance Device implantation as a destination therapy or as a bridge to transplantation,\nOptimal medical therapy.\n\nEXCLUSION CRITERIA:\n\nCardiothoracic surgery within 30 days prior to study entry,\nMyocardial infarction within 3 months prior to study entry,\nPrior cardiac transplantation,\nLeft Ventricular reduction surgery or cardiomyoplasty,\nAcute reversible cause of heart failure (e.g. myocarditis, profound hypothyroidism),\nLeft ventricular aneurysm or wall thickness preventing cell injections,\nAnticipated requirement for biventricular mechanical support,\nStroke within 30 days prior to study entry,\nReceived investigational intervention within 30 days of study entry,\nPregnant or breastfeeding at time of study entry,\nHuman Imune deficiency Virus, Human T-cell Lymphotrophic Virus, Hepatitis B Virus and Hepatitis C Virus positive within 30 days prior to study entry,\nActive systemic infection within 48 hours prior to study entry,\nHistory of cancer in the last 5 years,\nPatient participant to other research,\nPatient under treatment that may exert an inhibitory or stimulatory effect on the growth and multiplication of cells, or with immunosuppressive properties.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "75 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Roncalli JÃ©rome, MD, PhD",
            "OverallOfficialAffiliation": "Toulouse University Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Cardiology Department of Rangueil Hospital - Rangueil Hospital",
            "LocationCity": "Toulouse",
            "LocationZip": "31059",
            "LocationCountry": "France"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000017202",
            "ConditionMeshTerm": "Myocardial Ischemia"
          },
          {
            "ConditionMeshId": "D000007511",
            "ConditionMeshTerm": "Ischemia"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafAsFound": "Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5698",
            "ConditionBrowseLeafName": "Coronary Artery Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18658",
            "ConditionBrowseLeafName": "Myocardial Ischemia",
            "ConditionBrowseLeafAsFound": "Myocardial Ischemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8573",
            "ConditionBrowseLeafName": "Heart Failure",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          }
        ]
      }
    }
  }
}